Innovation Unit Ridgefield, Connecticut: Home to our Innovation in the USA

Our US headquarters in Ridgefield, Connecticut, is home to one of Boehringer Ingelheim's leading research and development sites. More than 1,900 employees, working across disciplines, are based at the 330 acre site which runs completely on renewable, hydro-electric energy.

Consistently rated as a Global Top Employer and ranked number six in the 2023 Pharmaceutical Innovation Index, our mission is to discover and develop breakthrough therapies for patients. Through our innovation strategy, our dedicated scientists are doing just that. They're tackling some of the most difficult challenges in healthcare today and, together with our external research partners, are working to accelerate the next breakthroughs that will transform patients' lives now and for generations to come. 


 

Our innovation strategy
Fostering Science | Boehringer Ingelheim US

Our Innovation Strategy: how we approach research and development

Disease never rests. So neither do we. Learn about how we are driving innovation in our research and development approach, with the patient at the core of everything with do.
Read more
Photo of female scientist
Human Health Innovation

Meet our scientist

Colleagues explain why they chose Boehringer Ingelheim
Read more